| Novel |
CCSER2
|
coiled-coil serine rich protein 2 |
|
|
|
| Novel |
DYDC1
|
DPY30 domain containing 1 |
|
|
|
| Novel |
DYDC2
|
DPY30 domain containing 2 |
|
|
|
| Novel |
KLLN
|
killin, p53 regulated DNA replication inhibitor |
|
|
|
| Novel |
PLCE1
|
phospholipase C epsilon 1 |
- Synthesis of IP3 and IP4 in the cytosol
|
|
- Nephrotic syndrome and focal segmental glomerulosclerosis
|
|
AGTR1
|
angiotensin II receptor type 1 |
- Peptide ligand-binding receptors
- G alpha (q) signalling events
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
|
- Valsartan
- Olmesartan
- Losartan
- Candesartan cilexetil
- Eprosartan
- Telmisartan
- Irbesartan
- Forasartan
- Saprisartan
- Tasosartan
- CYT006-AngQb
- Azilsartan medoxomil
- Fimasartan
- Angiotensin II
- Candesartan
|
|
|
CCR4
|
C-C motif chemokine receptor 4 |
- Chemokine receptors bind chemokines
- G alpha (i) signalling events
|
|
|
|
DRD2
|
dopamine receptor D2 |
|
- Amphetamine
- Ziprasidone
- Cabergoline
- Ropinirole
- Dihydroergotamine
- Olanzapine
- Clozapine
- Thiethylperazine
- Sulpiride
- Loxapine
- Remoxipride
- Pramipexole
- Promazine
- Prochlorperazine
- Droperidol
- Imipramine
- Chlorpromazine
- Buspirone
- Haloperidol
- Triflupromazine
- Nortriptyline
- Amoxapine
- Lamotrigine
- Cinnarizine
- Lisuride
- Fluphenazine
- Thioridazine
- Ergotamine
- Apomorphine
- Paroxetine
- Trimipramine
- Risperidone
- Propiomazine
- Minaprine
- Trifluoperazine
- Perphenazine
- Flupentixol
- Amantadine
- Mesoridazine
- Maprotiline
- Dopamine
- Carphenazine
- Memantine
- Ergoloid mesylate
- Acetophenazine
- Promethazine
- Pimozide
- Desipramine
- Escitalopram
- Domperidone
- Pergolide
- Bromocriptine
- Ketamine
- Quetiapine
- Metoclopramide
- Levodopa
- Aripiprazole
- Chlorprothixene
- Paliperidone
- Yohimbine
- Methotrimeprazine
- Alizapride
- Rolicyclidine
- Acepromazine
- Molindone
- Pipotiazine
- Thioproperazine
- Thiothixene
- Zuclopenthixol
- Aniracetam
- Fluspirilene
- Tetrabenazine
- Brasofensine
- Bifeprunox
- Bicifadine
- Itopride
- Iloperidone
- Rotigotine
- BL-1020
- Norclozapine
- Amitifadine
- Cariprazine
- Lumateperone
- YKP-1358
- Sertindole
- Mianserin
- Asenapine
- Ocaperidone
- Amisulpride
- Sarizotan
- Sumanirole
- Nandrolone decanoate
- Lurasidone
- Perospirone
- Bromopride
- Quinagolide
- Brexpiprazole
- Etoperidone
- AS-8112
- Blonanserin
- Melperone
- Zotepine
- Pipamperone
- Dihydro-alpha-ergocryptine
- Epicriptine
- Pardoprunox
- Tetrahydropalmatine
- Piribedil
- Raclopride
- JNJ-37822681
- Tiapride
- Dihydroergocristine
- Aripiprazole lauroxil
|
|
|
FAM209A
|
family with sequence similarity 209 member A |
|
|
|
|
FXYD3
|
FXYD domain containing ion transport regulator 3 |
- Ion homeostasis
- Ion transport by P-type ATPases
- Potential therapeutics for SARS
|
|
|
|
GPR35
|
G protein-coupled receptor 35 |
- Class A/1 (Rhodopsin-like receptors)
|
- Furosemide
- Pyrantel
- Kynurenic Acid
|
|
|
GPR37
|
G protein-coupled receptor 37 |
- Peptide ligand-binding receptors
- G alpha (i) signalling events
|
|
|
|
HTR2C
|
5-hydroxytryptamine receptor 2C |
- Serotonin receptors
- G alpha (q) signalling events
|
- Tramadol
- Ziprasidone
- Methysergide
- Cabergoline
- Dihydroergotamine
- Amitriptyline
- Olanzapine
- Clozapine
- Mirtazapine
- Loxapine
- Promazine
- Cyproheptadine
- Imipramine
- Fluoxetine
- Chlorpromazine
- Chlorpromazine
- Haloperidol
- Nortriptyline
- Amoxapine
- Fenfluramine
- Lisuride
- Fluphenazine
- Trazodone
- Ergotamine
- Apomorphine
- Paroxetine
- Trimipramine
- Risperidone
- Propiomazine
- Minaprine
- Flupentixol
- Cyclobenzaprine
- Maprotiline
- Ergoloid mesylate
- Tegaserod
- Doxepin
- Nefazodone
- Desipramine
- Escitalopram
- Pergolide
- Dexfenfluramine
- Bromocriptine
- Ketamine
- Quetiapine
- Aripiprazole
- Chlorprothixene
- Clomipramine
- Paliperidone
- Yohimbine
- Methotrimeprazine
- Midomafetamine
- 4-Bromo-2,5-dimethoxyphenethylamine
- Lorcaserin
- Dapoxetine
- Lofexidine
- Pimavanserin
- Epicept NP-1
- Cariprazine
- Sertindole
- Mianserin
- Pizotifen
- Asenapine
- Ocaperidone
- Dotarizine
- Deramciclane
- Agomelatine
- Esmirtazapine
- Nandrolone decanoate
- Captodiame
- Viloxazine
- Etoperidone
- Lorpiprazole
- Setiptiline
- Dihydroergocornine
- m-Chlorophenylpiperazine
- Gilteritinib
- Sarpogrelate
- Eplivanserin
- Tiapride
- Dihydroergocristine
- 2,5-Dimethoxy-4-ethylthioamphetamine
- Aripiprazole lauroxil
|
|
|
HTR4
|
5-hydroxytryptamine receptor 4 |
- Serotonin receptors
- G alpha (s) signalling events
|
- Dihydroergotamine
- Cisapride
- Paroxetine
- Ondansetron
- Ergoloid mesylate
- Tegaserod
- Metoclopramide
- Chlorprothixene
- Piboserod
- Renzapride
- Naronapride
- TD-2749
- Ticalopride
- Prucalopride
- Cinitapride
- Setiptiline
- Dihydroergocornine
- Gilteritinib
- Velusetrag
- Tiapride
- Dihydroergocristine
|
|
|
JSRP1
|
junctional sarcoplasmic reticulum protein 1 |
|
|
|
|
PGRMC2
|
progesterone receptor membrane component 2 |
- RHOA GTPase cycle
- RAC2 GTPase cycle
- RHOD GTPase cycle
- RHOG GTPase cycle
- RAC3 GTPase cycle
- Heme signaling
|
|
|
|
SLC22A1
|
solute carrier family 22 member 1 |
- Neurotransmitter clearance
- Norepinephrine Neurotransmitter Release Cycle
- Abacavir transmembrane transport
- SLC-mediated transport of neurotransmitters
- SLC-mediated transport of organic cations
- Ciprofloxacin ADME
|
|
|
|
TMEM242
|
transmembrane protein 242 |
|
|
|